Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37

被引:5
|
作者
Krishnamoorthy, Rajavenkatesh [1 ,2 ]
Adhikari, Priyanka [3 ]
Anaikutti, Parthiban [3 ]
机构
[1] CSIR CLRI, Organ & Bioorgan Chem Lab, Chennai 600020, Tamil Nadu, India
[2] Sethu Inst Technol, Dept Chem, Virudunagar 626115, Tamil Nadu, India
[3] Natl Inst Pharmaceut Educ & Res, Ctr GMP Extract Facil, Dept Biotechnol, Gauhati 781101, Assam, India
关键词
HOST-DEFENSE PEPTIDES; MECHANISM; MODEL; BIOMEMBRANES; SPECTROSCOPY; MEMBRANES; BILAYERS; INSIGHT; BINDING;
D O I
10.1039/d3ra02473c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We designed and synthesised the N-terminally labeled cationic and hydrophobic peptides, i.e., FFKKSKEKIGKEFKKIVQKI (P1) and FRRSRERIGREFRRIVQRI (P2) related to the human cathelicidin LL-37 peptide. The integrity and molecular weight of the peptides were confirmed by mass spectrometry. The purity and homogeneity of peptides P1 and P2 were determined by comparing LCMS or analytical HPLC chromatograms. The circular dichroism spectroscopy reveals the conformational transitions upon interaction with membranes. Predictably, peptides P1 and P2 showed a random coil structure in the buffer and formed alpha-helix secondary structure in TFE and SDS micelles. This assessment was further confirmed by 2D NMR spectroscopic methods. The analytical HPLC binding assay measurements revealed that peptides P1 and P2 display preferential interactions with the anionic lipid bilayer (POPC:POPG) moderately than zwitterionic (POPC). The efficacies of the peptides were tested against Gram-positive and Gram-negative bacteria. It is imperative to note here that the arginine-rich P2 exerted higher activity against all the test organisms as compared with that shown by the lysine-rich peptide P1. To test the toxicity of these peptides, a hemolytic assay was performed. P1 and P2 showed very little to no toxicity for a hemolytic assay, which is significant for P1 and P2 to be used as potential therapeutic agents in practical applications. Both peptides P1 and P2 were non-hemolytic and appeared to be more promising as they demonstrated wide-spectrum antimicrobial activity.
引用
收藏
页码:15594 / 15605
页数:12
相关论文
共 50 条
  • [31] Cathelicidin LL-37 Expression in Human Breast Implant Capsules
    Segreto, Francesco
    Carotti, Simone
    Marangi, Giovanni Francesco
    Francesconi, Maria
    Calia, Eleonora
    Cagli, Barbara
    Cimmino, Andrea
    Rossi, Caterina
    Morini, Sergio
    Persichetti, Paolo
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 153 (05) : 1066 - 1073
  • [32] Multifunctional roles of human cathelicidin (LL-37) at the ocular surface
    Huang, Ling C.
    Petkova, Tihomira D.
    Reins, Rose Y.
    Proske, Rita J.
    McDermott, Alison M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (06) : 2369 - 2380
  • [33] Human cathelicidin LL-37 prevents bacterial biofilm formation
    Jacobsen, Andreas S.
    Jenssen, Havard
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (12) : 1587 - 1599
  • [34] The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus
    Sheehan, Gerard
    Bergsson, Gudmundur
    McElvaney, Noel G.
    Reeves, Emer P.
    Kavanagh, Kevin
    INFECTION AND IMMUNITY, 2018, 86 (07)
  • [35] Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
    Zaiou, M
    Nizet, V
    Gallo, RL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (05) : 810 - 816
  • [36] Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration
    Findlay, Fern
    Pohl, Jan
    Svoboda, Pavel
    Shakamuri, Priyanka
    McLean, Kevin
    Inglis, Neil F.
    Proudfoot, Lorna
    Barlow, Peter G.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (07): : 2483 - 2490
  • [37] Expression of a human cathelicidin antimicrobial peptide, LL-37, in amniotic fluid with neonatal or maternal infection
    Yoshio, H
    Yamada, M
    Yoshida, M
    Takeuchi, A
    Fujii, S
    Kunii, Y
    Kageyama, M
    Yokoi, Y
    Yamauchi, Y
    Agerberth, B
    PEDIATRIC RESEARCH, 2005, 58 (02) : 427 - 427
  • [38] NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles
    Porcelli, Fernando
    Verardi, Raffaello
    Shi, Lei
    Henzler-Wildman, Katherine A.
    Ramamoorthy, Ayyalusamy
    Veglia, Gianluigi
    BIOCHEMISTRY, 2008, 47 (20) : 5565 - 5572
  • [39] Regulated expression of a unique antimicrobial peptide, cathelicidin LL-37, by human colon epithelium.
    Hase, K
    Eckmann, L
    Leopard, JD
    Varki, N
    Kagnoff, MF
    GASTROENTEROLOGY, 2001, 120 (05) : A182 - A182
  • [40] ANTIMICROBIAL PEPTIDE CATHELICIDIN (LL-37) CONCENTRATION IN ACTIVE PULMONARY TUBERCULOSIS PATIENTS
    Sovira, N.
    Sutoyo, D. K.
    Burhan, E.
    Dillon, D. H.
    RESPIROLOGY, 2012, 17 : 133 - 133